1-8 of 8
Andrew Raubitschek
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TLR9 Signaling in the Tumor Microenvironment Initiates Cancer Recurrence after Radiotherapy

Chan Gao, Anna Kozlowska, Sergey Nechaev, Haiqing Li, Qifang Zhang, Dewan M.S. Hossain, Claudia M. Kowolik, Peiguo Chu, Piotr Swiderski, Don J. Diamond, Sumanta K. Pal, Andrew Raubitschek, Marcin Kortylewski
Journal: Cancer Research
Cancer Res (2013) 73 (24): 7211–7221.
https://doi.org/10.1158/0008-5472.CAN-13-1314
Published: 16 December 2013
View article titled, TLR9 Signaling in the Tumor Microenvironment Initiates Cancer Recurrence after Radiotherapy
Open the PDF for TLR9 Signaling in the Tumor Microenvironment Initiates Cancer Recurrence after Radiotherapy in another window
Journal Articles

Combining Adoptive Cellular and Immunocytokine Therapies to Improve Treatment of B-Lineage Malignancy

Harjeet Singh, Lisa Marie Serrano, Timothy Pfeiffer, Simon Olivares, George McNamara, David D. Smith, Zaid Al-Kadhimi, Stephen J. Forman, Stephen D. Gillies, Michael C. Jensen, David Colcher, Andrew Raubitschek, Laurence J.N. Cooper
Journal: Cancer Research
Cancer Res (2007) 67 (6): 2872–2880.
https://doi.org/10.1158/0008-5472.CAN-06-2283
Published: 15 March 2007
View article titled, Combining Adoptive Cellular and Immunocytokine Therapies to Improve Treatment of B-Lineage Malignancy
Open the PDF for Combining Adoptive Cellular and Immunocytokine Therapies to Improve Treatment of B-Lineage Malignancy in another window
Includes: Multimedia, Supplementary data
Journal Articles

Specific Recognition and Killing of Glioblastoma Multiforme by Interleukin 13-Zetakine Redirected Cytolytic T Cells

Kanwarpal S. Kahlon, Christine Brown, Laurence J. N. Cooper, Andrew Raubitschek, Stephen J. Forman, Michael C. Jensen
Journal: Cancer Research
Cancer Res (2004) 64 (24): 9160–9166.
https://doi.org/10.1158/0008-5472.CAN-04-0454
Published: 16 December 2004
View article titled, Specific Recognition and Killing of Glioblastoma Multiforme by Interleukin 13-Zetakine Redirected Cytolytic T Cells
Open the PDF for Specific Recognition and Killing of Glioblastoma Multiforme by Interleukin 13-Zetakine Redirected Cytolytic T Cells in another window
Journal Articles

Minibody: A Novel Engineered Anti-Carcinoembryonic Antigen Antibody Fragment (Single-Chain Fv-CH3) Which Exhibits Rapid, High-Level Targeting of Xenografts

Shi-zhen Hu, Louise Shively, Andrew Raubitschek, Mark Sherman, Lawrence E. Williams, Jeffrey Y. C. Wong, John E. Shively, Anna M. Wu
Journal: Cancer Research
Cancer Res (1996) 56 (13): 3055–3061.
Published: 01 July 1996
View article titled, Minibody: A Novel Engineered Anti-Carcinoembryonic Antigen Antibody Fragment (Single-Chain Fv-C<sub>H</sub>3) Which Exhibits Rapid, High-Level Targeting of Xenografts
Open the PDF for Minibody: A Novel Engineered Anti-Carcinoembryonic Antigen Antibody Fragment (Single-Chain Fv-C<sub>H</sub>3) Which Exhibits Rapid, High-Level Targeting of Xenografts in another window
Journal Articles

The Emerging Biology of Modern Radiation Oncology

Thomas E. Goffman, Andrew Raubitschek, James B. Mitchell, Eli Glatstein
Journal: Cancer Research
Cancer Res (1990) 50 (24): 7735–7744.
Published: 01 December 1990
View article titled, The Emerging Biology of Modern Radiation Oncology
Open the PDF for The Emerging Biology of Modern Radiation Oncology in another window
Journal Articles

Innovations That Influence the Pharmacology of Monoclonal Antibody Guided Tumor Targeting

Jeffrey Schlom, Patricia Horan Hand, John W. Greiner, David Colcher, Shashi Shrivastav, Jorge A. Carrasquillo, James C. Reynolds, Steven M. Larson, Andrew Raubitschek
Journal: Cancer Research
Cancer Res (1990) 50 (3_Supplement): 820s–827s.
Published: 01 February 1990
View article titled, Innovations That Influence the Pharmacology of Monoclonal Antibody Guided Tumor Targeting
Open the PDF for Innovations That Influence the Pharmacology of Monoclonal Antibody Guided Tumor Targeting in another window
Journal Articles

Nature of the Bifunctional Chelating Agent Used for Radioimmunotherapy with Yttrium-90 Monoclonal Antibodies: Critical Factors in Determining in Vivo Survival and Organ Toxicity

Robert W. Kozak, Andrew Raubitschek, Saed Mirzadeh, Martin W. Brechbiel, Richard Junghaus, Otto A. Gansow, Thomas A. Waldmann
Journal: Cancer Research
Cancer Res (1989) 49 (10): 2639–2644.
Published: 01 May 1989
View article titled, Nature of the Bifunctional Chelating Agent Used for Radioimmunotherapy with Yttrium-90 Monoclonal Antibodies: Critical Factors in Determining <em>in Vivo</em> Survival and Organ Toxicity
Open the PDF for Nature of the Bifunctional Chelating Agent Used for Radioimmunotherapy with Yttrium-90 Monoclonal Antibodies: Critical Factors in Determining <em>in Vivo</em> Survival and Organ Toxicity in another window
Journal Articles

Characterization and Biodistribution of Recombinant and Recombinant/Chimeric Constructs of Monoclonal Antibody B72.3

David Colcher, Diane Milenic, Mario Roselli, Andrew Raubitschek, Geoffrey Yarranton, David King, John Adair, Nigel Whittle, Mark Bodmer, Jeffrey Schlom
Journal: Cancer Research
Cancer Res (1989) 49 (7): 1738–1745.
Published: 01 April 1989
View article titled, Characterization and Biodistribution of Recombinant and Recombinant/Chimeric Constructs of Monoclonal Antibody B72.3
Open the PDF for Characterization and Biodistribution of Recombinant and Recombinant/Chimeric Constructs of Monoclonal Antibody B72.3 in another window